Podcast
The Uromigos
Hosted by The Uromigos · EN
Broadcasting the latest developments in GU cancer
Hosted by Brian Rini and Tom Powles
Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center
Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
492episodes
Episodes
Newest firstAll episodes
Episode 434: IMPACT series - A Walk Through the History of VEGF TKI Development in RCC
Aug 4, 202500:48:51Tap to summarizeDanny Heng joins to tour through VEGF TKI drug development from sorafenib to tivozanib and everything in between.
Transcribe →Episode 433: Uromigos Japan - 改訂版ASCO mCRPCガイドライン
Aug 1, 202500:39:46Tap to summarize5月に改訂されたASCOのmCRPC薬物療法のガイドラインについて3人でディスカッションしました！！評価はいかに？
Transcribe →Episode 432: ASCO 2025 Rapid Oral Session RCC/Bladder Recap
Jul 21, 202500:27:49Tap to summarizeKarie Runcie, MD joins us after chairing the ASCO 2025 rapid oral session to discuss the rcc/bladder presentations.
Transcribe →Episode 431: IMPACT series - Axel Bex on Impactful RCC Clinical Trials
Jul 14, 202500:43:59Tap to summarizeAxel Bex joins the show to discuss trials that he thinks have impacted RCC. We also discuss consolidative approaches, neoadjuvant trials and what can impact an academic career.
Transcribe →Episode 430: Structured Exercise Improves DFS/OS after Adjuvant Therapy in Colorectal Cancer - Does This Apply to GU Cancers?
Jul 7, 202500:45:46Tap to summarizeChris Booth joins the show to discuss his recent NEJM paper that demonstrated significant DFS and OS improvements with a structured exercise program after adjuvant chemo in colorectal cancer. We discuss implications for GU and other malignancies.
Transcribe →Episode 429: ASCO2025レポート
Jul 2, 202500:42:47Tap to summarizeASCO2025の注目演題を取り上げ解説、ディスカッションしました！
Transcribe →Episode 428: ASCO 2025 Recap
Jun 16, 202500:54:20Tap to summarizeBrian, Tom and Silke discuss their highlights form ASCO 2025
Transcribe →Episode 427: Emerging Data in Non-muscle Invasive Bladder Cancer (NMIBC)
Jun 13, 202500:40:27Tap to summarizeJosh Meeks joins us to give stellar overview of the emerging data in this space. We also discuss the recent ODAC ruling for lower risk patients.
Transcribe →Episode 426 - ASCO 2025: AMPLITUDE Phase 3 of PARPi in mHSPC
Jun 6, 202500:37:22Tap to summarizeGert Attard joins us to discuss this practice-changing data and the highlight of ASCO 2025
Transcribe →Episode 425: ASCO 2025 - AI-enabled selection of patients for benefit of ADT + ARPI
Jun 4, 202500:19:39Tap to summarizeNick James discusses intriguing data from STAMPEDE to us AI to analyze pathology slides to predict benefit from ADT + abiraterone
Transcribe →